TuHURA Biosciences
HURA
24 hedge funds and large institutions have $1.99M invested in TuHURA Biosciences in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
0% more funds holding
Funds holding: 24 → 24 (0)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
57% less capital invested
Capital invested by funds: $4.65M → $1.99M (-$2.65M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$226K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$192K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$174K |
| 4 |
Renaissance Technologies
New York
|
+$157K |
| 5 |
VF
Virtu Financial
New York
|
+$39.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.75M |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$403K |
| 3 |
GSEP
Golden State Equity Partners
South Coast Metro,
California
|
-$55K |
| 4 |
RE
RBC Europe
London,
United Kingdom
|
-$32.4K |
| 5 |
RFA
Reilly Financial Advisors
La Mesa,
California
|
-$22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
26
Boothbay Fund Management
New York
| – | -$403K | -268 | Closed |
|
|
GSEP
27
Golden State Equity Partners
South Coast Metro,
California
| – | -$55K | -37 | Closed |
|
|
RE
28
RBC Europe
London,
United Kingdom
| – | -$32.4K | -22 | Closed |
|
29
Fidelity Investments
Boston,
Massachusetts
| – | -$13K | -9 | Closed |
|
|
RFA
30
Reilly Financial Advisors
La Mesa,
California
| – | -$22K | – | – |
|
HURA Hedge Fund Activity: Q4 2021 in Review
24 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2021, worth a combined $1.99M — down 57% from $4.65M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HURA positions and 5 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $226K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.75M sold.
- 24 institutional investors held TuHURA Biosciences (HURA) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $1.99M of TuHURA Biosciences stock for Q4 2021, down 57% quarter-over-quarter.
- 6 funds opened new TuHURA Biosciences positions in Q4 2021 and 5 closed out, a net change of +1 holder.
- The largest TuHURA Biosciences buyer in Q4 2021 was Vanguard Group, an estimated $226K added.
- The largest TuHURA Biosciences seller in Q4 2021 was Armistice Capital, an estimated $1.75M sold.
Based on aggregated 13F filings for Q4 2021.